Huber Reid M
- SEC CIK
- 0001607052
No open-market purchases or sales filed in the past year.
Current role at each company
- RAPP Rapport Therapeutics, Inc.Directoras of Jun 10, 2026
- CRGX CARGO Therapeutics, Inc.Directoras of Aug 19, 2025
- TNGX Tango Therapeutics, Inc.Directoras of Jun 8, 2023
- Bellicum Pharmaceuticals, IncDirectoras of Jan 20, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Huber Reid M as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
RAPP Rapport Therapeutics, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 15, 2025 (view filing) | Sep 12 | 3 days | Huber Reid MDirector | PPurchase | +20.4K | $24.48 | +$499.4K | New position20.4K after |